 The gross proceeds from this offering are expected to be 30 million, before deducting underwriting discounts and commissions, and offering expenses payable by Misonix. In addition, Misonix has granted the underwriters a 30-day option to purchase up to an additional 243,750 shares of its common stock on the same terms and conditions. Misonix intends to use the net proceeds from the offering for general corporate purposes, which may include investment in sales and marketing initiatives and funding growth opportunities such as collaborations and acquisitions of complementary products or technologies. 